Otonomy (OTIC) Provides Update on Clinical Trials, Development Programs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Otonomy Provides Update on Clinical Trials and Development Programs
June 15, 2020 4:05 PM UTCResults from Phase 3 trial of OTIVIDEX® in Ménières disease expected in first quarter of 2021Results from Phase 1/2 trial of OTO-313 in tinnitus expected in July 2020Results from Phase 1/2 trial of OTO-413 in hearing loss expected in fourth quarter of 2020Current capital funds operations through all clinical trial readouts
Conference call and webcast today at 4:30 p.m. ET
SAN DIEGO, June 15, 2020 (GLOBE NEWSWIRE) -- Otonomy,... More
